Long lasting complete regression of a metastatic polyomavirus-positive Merkel cell carcinoma after COVID-19 booster vaccination
Merkel cell carcinoma (MCC) is a rare but highly aggressive primary cutaneous neuroendocrine cancer whose incidence is increasing worldwide. MCC represents the second leading cause of skin cancer death after melanoma [1,2]. It typically manifests as a red nodule or plaque with fast growth, most commonly on sun exposed areas [3]. Risk factors include fair skin type, advanced age, ultraviolet radiation exposure, male sex, immunosuppression, and integration of Merkel cell polyomavirus DNA (MCPyV) into the host genome [3].
Authors
- Ulrike Wieland (ORCID: https://orcid.org/0000-0003-3480-4413)
- H. M. Kvasnicka (ORCID: https://orcid.org/0000-0002-3081-1395)
- Ahmet Bozkurt (ORCID: https://orcid.org/0000-0002-2449-4776)
- Silke Hofmann (ORCID: https://orcid.org/0000-0002-4221-386X)
- Ulrich Wesselmann
Institutions
- Helios Universitätsklinikum Wuppertal (DE)
- University Hospital Cologne (DE)
Publication Details
- Journal
- EJC Skin Cancer
- Published
- 2024-10-23
- DOI
- https://doi.org/10.1016/j.ejcskn.2024.100275
- Citations
- 1
- Primary Topic
- Polyomavirus and related diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.28